Council For Citizens Against Government Waste America's #1 Taxpayer Watchdog

As the debate over Speaker Nancy Pelosi’s (D-Calif.) effort to increase government control over drug pricing heats up, a familiar proposal has also drawn scrutiny.

The healthcare policy community is anxiously waiting to see what kind of pharmaceutical pricing legislation Senate Finance Committee Chairman Chuck Grassley (R-Iowa) and Ranking Member Ron Wyden (D-Ore.) will produce for Medicare and Medicaid drug plans when Congress returns from the Independence Day break.  Will the shallow, but damaging, policy of instituting price controls be utilized or will enhanced competitive private-sector negotiations be allowed to take hold?  Because competition always leads to lower costs and more innovation, Citizens Against Government Waste (CAGW) hopes it is t

On June 19, 2019, New York Governor Andrew Cuomo indicated he would be willing to sign the Climate and Community Protection Act into law.

As the American Medical Association’s (AMA) shrinking membership tilts further and further to the left, real questions need to be asked about the organization’s influence over the Medicare for All debate.